| Year |
Citation |
Score |
| 2019 |
Lin L, Rybak AP, Rinaldi C, Yen J, Fu Y, Akrawi E, Smith S, Haskett SJ, Sanchez ME, Poh Y, Packer MS, Gaudelli NM, Singh M, Ciaramella G, Levasseur DN. Complementary Base Editing Approaches for the Treatment of Sickle Cell Disease and Beta Thalassemia Blood. 134: 3352-3352. DOI: 10.1182/Blood-2019-126710 |
0.35 |
|
| 2017 |
Garrison BS, Rybak AP, Beerman I, Heesters B, Mercier FE, Scadden DT, Bryder D, Baron R, Rossi DJ. ZFP521 regulates murine hematopoietic stem cell function and facilitates MLL-AF9 leukemogenesis in mouse and human cells. Blood. PMID 28615219 DOI: 10.1182/Blood-2016-09-738591 |
0.432 |
|
| 2016 |
Kapoor A, Wu C, Shayegan B, Rybak AP. Contemporary agents in the management of metastatic castration-resistant prostate cancer. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. 10: E414-E423. PMID 28096932 DOI: 10.5489/Cuaj.4112 |
0.318 |
|
| 2015 |
Rybak AP, Bristow RG, Kapoor A. Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression. Oncotarget. 6: 1900-19. PMID 25595909 DOI: 10.18632/Oncotarget.2953 |
0.488 |
|
| 2014 |
Bruce A, Rybak AP. CYB5D2 requires heme-binding to regulate HeLa cell growth and confer survival from chemotherapeutic agents. Plos One. 9: e86435. PMID 24466094 DOI: 10.1371/Journal.Pone.0086435 |
0.356 |
|
| 2013 |
Rybak AP, Tang D. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells. Cellular Signalling. 25: 2734-42. PMID 24036214 DOI: 10.1016/J.Cellsig.2013.08.041 |
0.515 |
|
| 2013 |
Rybak AP, Ingram AJ, Tang D. Propagation of Human Prostate Cancer Stem-Like Cells Occurs through EGFR-Mediated ERK Activation Plos One. 8. PMID 23620784 DOI: 10.1371/Journal.Pone.0061716 |
0.443 |
|
| 2012 |
Xie Y, Yan J, Cutz JC, Rybak AP, He L, Wei F, Kapoor A, Schmidt VA, Tao L, Tang D. IQGAP2, A candidate tumour suppressor of prostate tumorigenesis. Biochimica Et Biophysica Acta. 1822: 875-84. PMID 22406297 DOI: 10.1016/J.Bbadis.2012.02.019 |
0.47 |
|
| 2011 |
He L, Fan C, Kapoor A, Ingram AJ, Rybak AP, Austin RC, Dickhout J, Cutz JC, Scholey J, Tang D. α-Mannosidase 2C1 attenuates PTEN function in prostate cancer cells. Nature Communications. 2: 307. PMID 21556061 DOI: 10.1038/Ncomms1309 |
0.394 |
|
| 2011 |
Rybak AP, He L, Kapoor A, Cutz JC, Tang D. Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells. Biochimica Et Biophysica Acta. 1813: 683-94. PMID 21277911 DOI: 10.1016/J.Bbamcr.2011.01.018 |
0.562 |
|
| 2011 |
Rybak A, Kapoor A, He L, Tang D. 168 Defining Conditions To Generate And Maintain Prostate Cancer Stem Cells The Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.237 |
0.493 |
|
| 2010 |
He L, Ingram A, Rybak AP, Tang D. Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells. The Journal of Clinical Investigation. 120: 2094-108. PMID 20458142 DOI: 10.1172/Jci40778 |
0.499 |
|
| 2009 |
Fan C, He L, Kapoor A, Rybak AP, De Melo J, Cutz JC, Tang D. PTEN inhibits BMI1 function independently of its phosphatase activity. Molecular Cancer. 8: 98. PMID 19903340 DOI: 10.1186/1476-4598-8-98 |
0.422 |
|
| 2008 |
Fan C, He L, Kapoor A, Gillis A, Rybak AP, Cutz JC, Tang D. Bmi1 promotes prostate tumorigenesis via inhibiting p16(INK4A) and p14(ARF) expression. Biochimica Et Biophysica Acta. 1782: 642-8. PMID 18817867 DOI: 10.1016/J.Bbadis.2008.08.009 |
0.431 |
|
| 2007 |
Dregoesc D, Rybak AP, Rainbow AJ. Increased expression of p53 enhances transcription-coupled repair and global genomic repair of a UVC-damaged reporter gene in human cells. Dna Repair. 6: 588-601. PMID 17196445 DOI: 10.1016/J.Dnarep.2006.11.008 |
0.358 |
|
| Show low-probability matches. |